Iron Hill Capital believes the life sciences industry is rapidly evolving and the next decade will be marked by a revolution in health care driven by new therapeutics and technologies, life cycle management of existing drugs and devices, and participation of new global players.

Our goal is to support global life science companies that are building on these technical  breakthroughs and market changes to commercialize new or improved health care products.

Iron Hill Capital espouses a proven, well-developed Global Partnership Strategy – a strategy rooted in combining investment professionals with industry experts.  Our investment partners take an active role in supporting strong management teams and working with portfolio companies to develop strategic plans, enhance organic growth, pursue value creating acquisitions and increase operational efficiencies. Our industry partners provide the strategic insight and operational oversight  to help drive growth and performance, creating long-term value.